Product Program year 2022 Source: CMS Open Payments

Fluarix Quadrivalent

Biological Vaccines

NDC 58160-890-52

Open in the dashboard

General payments

$17,258

772 payments

Research payments

$0

0 payments

Through program year 2022, $17,258 in general payments and $0 in research payments were reported against Fluarix Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $17,214 769
2021 General $13 1
2019 General $31 2

Breakdown

Who paid General payments · program years 2019–2022
  1. GlaxoSmithKline, LLC. $17,258 772 payments
Top recipients General payments · program year 2022
  1. Childrens Hospital Colorado Teaching hospital · CO $3,000 17% · 1 payment
  2. Joan Purcell Adolescent Medicine · The Woodlands, TX $203 1% · 3 payments
  3. Sarah Bourland Pediatrics · San Antonio, TX $198 1% · 3 payments
  4. Joseph Edralin Pediatrics · The Woodlands, TX $176 1% · 3 payments
  5. Jamie Ngo Pediatrics · Sugar Land, TX $137 <1% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Pediatrics $4,079 29% · 153 practitioners
  2. Family Medicine $3,266 23% · 136 practitioners
  3. Internal Medicine $2,459 17% · 110 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $1,533 11% · 74 practitioners
  5. Nurse Practitioner $524 4% · 24 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $4,944 29% · 149 recipients
  2. Colorado $3,206 19% · 15 recipients
  3. Tennessee $2,461 14% · 143 recipients
  4. New York $1,780 10% · 68 recipients
  5. Mississippi $956 6% · 26 recipients

The top 5 of 33 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

772 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record